Investing in clinical intelligence for the youth mental-health front door
UIZ.CARE is building clinical decision-support infrastructure for young people aged 15–24 and the General Practitioners who care for them.Primary care is often the first place where emotional, behavioural and psychosocial distress appears. Yet GPs must make complex triage and referral decisions with fragmented information, limited consultation time and growing administrative pressure. Young people, meanwhile, may struggle to recognise or articulate early signs of deterioration.UIZ.CARE connects these two realities: a digital-first interface for young people and a workflow-embedded clinical view for GPs. The platform structures pre-assessment, supports explainable triage signals, improves follow-up and creates a foundation for more coordinated, data-informed care.This is not another consumer mental-health app. It is infrastructure designed for clinical workflows, evidence generation and responsible scale.
Why UIZ.CARE Is Investable Today
Digital health succeeds only when technology, clinical practice, regulation and commercial incentives move together.UIZ.CARE has progressed from early product development into feasibility validation and regulatory preparation. Its pilot work has generated a clear operational signal: in the observed GP cohort, administrative workload decreased by 47%, equivalent to approximately 8.7 hours per GP per week. Overall usability reached a System Usability Scale score of 76.99.The pilot was not designed to prove clinical outcomes, diagnostic accuracy or referral reduction. It did, however, establish the technical, workflow and quality-management foundations required for the next phase: prospective clinical validation, human-factors optimisation, MDR Class IIa readiness and structured commercial deployment.That distinction matters. We are raising capital to turn promising feasibility evidence into a clinically governed, reimbursable and scalable care infrastructure.
The Opportunity
Youth mental health is under growing pressure across Europe. Primary care is carrying much of the operational burden, while specialist-care pathways face long waiting times, referral uncertainty and constrained capacity.For GP practices, UIZ.CARE is designed to reduce friction at the front door of care: better structured intake, clearer information before consultation, more consistent triage and more efficient follow-up.For networks, payers and public-health partners, it offers a future measurement layer for care pathways, service demand and resource allocation. Clinical and economic claims—including referral optimisation and system savings—will be validated through the next evidence programme rather than assumed.The Netherlands is UIZ.CARE’s launch market. Germany and selected European markets provide the longer-term expansion opportunity once evidence, regulatory progress and repeatable deployment are established.
Built for Healthcare Systems, Not Consumer Apps
UIZ.CARE operates a B2B2C model.Young people use a digital interface to capture symptoms, validated questionnaires and relevant daily signals. GP practices use a clinical dashboard designed to support intake, triage, documentation and follow-up. Over time, GP networks, insurers and institutional partners can deploy the platform through structured programmes and outcome-oriented contracts.The commercial model combines:GP software subscriptions;Optional youth premium modules;Institutional, network and payer contracts; andFuture outcome-oriented reimbursement mechanisms, subject to validation and contracting.The near-term focus is deliberately practical: prove workflow value, improve engagement, generate clinical evidence and establish the first repeatable paid deployments.
Strong Foundations, Clear Next-Stage Work
UIZ.CARE has established a foundation across product, workflow, safety and governance:A feasibility-stage platform tested with GPs and young people;An operational efficiency signal from the GP pilot;A structured quality and regulatory documentation base;SaMD positioning with a likely MDR Class IIa pathway;Explainable clinical-intelligence logic through the Peace Score framework;Interoperability and workflow-integration development; andPartnerships supporting clinical, technical and evidence-generation progress.The next phase is equally clear: improve early-stage engagement and retention, complete prospective clinical and health-economic validation, harden the quality system and progress toward regulated deployment.
Sustainable Competitive Position
Artificial intelligence alone is not a durable advantage in healthcare.UIZ.CARE’s long-term defensibility is expected to come from the combination of clinical workflow integration, explainable decision support, quality systems, evidence generation, interoperable architecture, institutional relationships and real-world implementation learning.Every successful deployment should strengthen both the product and the evidence base required to scale responsibly.
A Disciplined Use of Capital
The current seed round will fund the milestones that most directly reduce risk and create enterprise value:Clinical validation, human-factors research and health-economic evidence; MDR Class IIa readiness, quality management and post-market surveillance capability; EU AI Act-aligned governance and data protection;Product hardening, cybersecurity and interoperability pathways;Dutch GP, network and institutional deployment; andCommercial preparation for Germany and wider European expansion. UIZ.CARE’s growth strategy combines equity with non-dilutive funding where available. Grant opportunities are treated as target funding pathways—not as secured capital—until formally awarded.
Why Now
The conditions for clinical intelligence in primary care are converging.Youth mental-health needs are rising. GP capacity is under sustained pressure. Healthcare systems are seeking better prevention, earlier recognition and more efficient care pathways. At the same time, European regulation is raising the bar for trustworthy AI and creating a meaningful advantage for companies able to combine evidence, governance and clinical integration.UIZ.CARE is positioned to meet that moment with a focused entry point: helping primary care better support young people before distress becomes a crisis.
Investment Thesis
UIZ.CARE is building the clinical intelligence layer for the youth mental-health front door of primary care. The company has moved beyond concept stage and established feasibility, workflow and quality foundations. The seed round funds the transition to regulated, evidence-led commercialisation: prospective validation, adoption optimisation, MDR progression and the first repeatable institutional deployments.For investors, the opportunity is to support a European health-technology company addressing a structural care-capacity challenge with a disciplined, clinically governed model.Youth mental health is the starting point. The ambition is to create a trusted infrastructure for earlier recognition, clearer clinical decisions and more connected primary care.
